seaspine
-
Spine
SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System
CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance
CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility
Provides for up to an additional $10 million of liquidity CARLSBAD, Calif., July 19, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of WaveForm® C 3D-printed Interbody System
Company’s second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million…
Read More » -
Spine
SeaSpine Announces Full Commercial Launch of the WaveForm™ TO (TLIF Oblique) 3D-Printed Interbody System
Company’s first full commercial launch of novel 3D printed interbody product franchise that addresses estimated $500 million market opportunity. CARLSBAD,…
Read More » -
Financial
SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance
CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces New Senior Leadership Team Appointments
CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces Full Commercial Launch of OsteoTorrent™ DBM Product Families
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine Announces Full Commercial Launch of the Reef® TA (TLIF Articulating) Interbody System
CARLSBAD, Calif., April 11, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Spine
SeaSpine® Announces 50,000th NanoMetalene® Implantation
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results
Provides 2022 Revenue Guidance CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical…
Read More » -
Spine
SeaSpine® Announces New Senior Leadership Team Appointments
CARLSBAD, Calif., March 07, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical…
Read More » -
Biologics
SeaSpine® Announces Full Commercial Launch of NorthStar™ Facet Fusion and Limited Commercial Launch of FLASH™ Navigation Lumbar Facet Fusion
CARLSBAD, Calif., March 01, 2022 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…
Read More » -
Financial
SeaSpine to Host Virtual Analyst and Investor Day on March 11, 2022
Announces Date of Fourth Quarter and Full Year 2021 Financial Results Conference Call CARLSBAD, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE)…
Read More »